Patient-reported versus pharmacy-verified naloxone co-prescription fill rates in a chronic pain clinic: a cross-sectional discordance analysis
- 7 August 2026
- journal article
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 27 (10) , 1158-1160
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Agreement between Patient-reported Pain Medication Use and Electronic Medical Record Data in Surgical Amputation PatientsPlastic and Reconstructive Surgery - Global Open, 2023
- CDC Clinical Practice Guideline for Prescribing Opioids for Pain—United States, 2022MMWR. Recommendations and Reports, 2022
- Vital Signs: Pharmacy-Based Naloxone Dispensing — United States, 2012–2018MMWR. Morbidity and Mortality Weekly Report, 2019
- Naloxone Co-prescribing to Patients Receiving Prescription Opioids in the Medicare Part D Program, United States, 2016-2017JAMA, 2019
- Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United StatesJAMA Network Open, 2019
- Acceptability of Naloxone Co-Prescription Among Primary Care Providers Treating Patients on Long-Term Opioid Therapy for PainJournal of General Internal Medicine, 2016
- Attitudes Toward Naloxone Prescribing in Clinical Settings: A Qualitative Study of Patients Prescribed High Dose Opioids for Chronic Non-Cancer PainJournal of General Internal Medicine, 2016
- Primary Care Patient Experience with Naloxone PrescriptionThe Annals of Family Medicine, 2016
- A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming into Clinical PracticeSubstance Abuse, 2015